Brand comparison
Ro vs MEDVi
Short answer: Ro and MEDVi sell different things. Ro sells FDA-approved brand-name medication with a Ro Body membership: $39 for the first month, then $74 to $149 a month by plan, plus medication from $149 a month at the starting dose, so $298 a month on the monthly plan (checked 31 October 2026). MEDVi's main plans are compounded GLP-1 injections, which are not FDA approved, at an introductory $99 for the first month and $199 for refills, with no membership (checked 31 October 2026). Ro has no FDA warning letter on record; MEDVi has one.
For anyone weighing a brand-name membership against a compounded programme. Every figure is read from each provider's own pages or its public record, with the date.
Quick editorial read
Ro sells FDA-approved brand-name medication behind a membership, with an insurance check and the price at every dose published; MEDVi sells compounded GLP-1 at a lower figure with no membership, and names its pharmacies and refund terms. Ro's public record is clean on the FDA; MEDVi's carries a warning letter, open lawsuits and a breach at its prescriber network. This page sets out what each states. It does not rank one above the other.
Ro vs MEDVi: the costs side by side
A membership plus brand-name medication against a compounded plan with no membership. The totals are not like for like, and the table says where.
| Ro | MEDVi | |
|---|---|---|
| What you pay for | A Ro Body membership, plus brand-name medication as a second, separate charge | One compounded GLP-1 plan with no membership fee, as MEDVi states; branded routes are sold separately as a membership plus the medication |
| Entry price | Membership $39 for the first month, refunded if you are not eligible for GLP-1s; medication from $149 a month at the starting dose, so $188 for month one (checked 31 October 2026) | An introductory $99 for the first month of compounded GLP-1 injections, shown inside a sale banner (checked 31 October 2026) |
| Ongoing cost | Membership $149 monthly, $99 a month on the 3-month plan, $89 on the 6-month plan or $74 on the 12-month plan prepaid annually, plus medication: $298 a month monthly, $223 on the 12-month plan, at the starting dose. Medication prices rise with the dose | Refills at $199, which MEDVi says are "locked in" |
| What is included | Provider review, ongoing check-ins, 1:1 messaging and an insurance concierge; the medication is the second charge | The prescription, one-to-one physician guidance, 24/7 support and dietician visits and care coaching, the last qualified by an asterisk on insurance and copay eligibility; shipping is free |
| Medication | Brand-name only: the Wegovy pill and pen, the Foundayo pill, Zepbound and Ozempic; no compounded GLP-1 listed (pages read 18 October 2026) | Compounded GLP-1 injections and tablets; not FDA approved, as MEDVi states. Branded medicines are a separate membership route |
| Price at each dose | Published for every dose; the Wegovy pill starts at $149 and Zepbound at $299 | One price per plan; MEDVi does not say whether it changes with the dose |
| Insurance | Free insurance check and a concierge for Ozempic, Wegovy and the Zepbound pens; with coverage your medication cost may be your copay | Not required on the compounded plans; HSA/FSA approved, as MEDVi states |
| Who prescribes | Ro's licensed providers, after an online intake; Ro says it only charges the membership if you are eligible | OpenLoop Health clinicians, in a consultation after checkout; MEDVi states its own assessment does not create a doctor-patient relationship |
| Pharmacy | Cash-pay medication ships to your door; insured medication is picked up at your pharmacy | Three named: Triad Rx, Red Rock Home Pharmacy and Beaker Pharmacy; MEDVi does not say which fills a given order |
| Cancellation and refunds | The first month's membership is refunded if you are not eligible; otherwise the membership fee is non-refundable once paid, prescription products are final sale, and you must cancel at least 48 hours before renewal (terms read 18 October 2026) | Cancel at least 72 hours before the next billing date; full refund within the first 72 hours before any service, or on medical disqualification; no refund for the month of cancellation (policy read 18 October 2026) |
| States served | Varies by state, insurance and clinical eligibility; no list published | Not published; MEDVi says availability depends on the state you are in |
| FDA warning letter | None found (fda.gov search, 18 October 2026) | 721455, 20 February 2026, on the labelling and marketing of its compounded GLP-1 products; no close-out shown on 18 October 2026 |
| Lawsuits and data breach | None recorded on our Ro review | Named as defendant in three federal cases (one settled, two open on 28 October 2026); the data breach attached to its name is at OpenLoop Health, its prescriber network, not at MEDVi (checked 28 October 2026) |
| Trustpilot | 3.9 from 7,231 reviews (read 18 October 2026) | 4.3 from 15,102 reviews (read 26 October 2026) |
| BBB | A+, 747 complaints in three years (read 18 October 2026) | F, 782 complaints in three years (read 22 October 2026) |
Prices from each provider's own pages, read daily into our archive; the dates shown are the latest read. Ro totals are our arithmetic: membership plus the lowest starting-dose medication price. Trustpilot and BBB figures are as each site showed them on the date given. Compounded medicines are not FDA-approved.
From
$149/mo
medication, Wegovy pill
+ membership
Membership from $74/mo, $39 the first month. Medication is a separate charge.
Checked 31 Oct 2026.
Ro Body membership plus brand-name GLP-1 medication, with a free insurance check.
- Treatments
- Wegovy pill, Foundayo pill, Wegovy pen, Zepbound, +1 more
- Available
- US only
- Pricing
- Published, checked 31 Oct 2026
Compounded GLP-1 injections, including tirzepatide, and tablets, plus branded routes.
- Treatments
- Compounded GLP-1 injections, Compounded tirzepatide, Compounded GLP-1 tablets, Branded GLP-1
- Available
- US, varies by state
- Pricing
- Published, checked 31 Oct 2026
At-a-glance comparison
Ro.co
Full profile- Best for
- People who want FDA-approved brand-name GLP-1 medication (the Wegovy pill, Foundayo, the Wegovy pen or Zepbound) from a large, established telehealth company, and who may want to try insurance first. It suits less well anyone looking for the lowest possible monthly cost, because compounded programmes print lower prices and Ro sells brand-name medication only.
- Pricing
- Ro Body membership: $39 for the first month, then $149 a month on the monthly plan, $99 on the 3-month plan, $89 on the 6-month plan or $74 on the 12-month plan prepaid annually. Medication is a second charge: the Wegovy pill and Foundayo pill start at $149 a month and Zepbound KwikPen at $299. At the lowest starting dose, month one comes to $188 and each month after to $298 on the monthly plan (our arithmetic on Ro's figures, checked 31 October 2026).
- Access
- FDA-approved brand-name medication only: the Wegovy pill (daily semaglutide tablet), the Foundayo pill (daily orforglipron), the Wegovy pen (weekly semaglutide), Zepbound as a KwikPen and a pen (weekly tirzepatide), and Ozempic. No compounded GLP-1 is listed on Ro's weight-loss pages read on 18 October 2026.
MEDVi
Full profile- Best for
- Buyers who want the supply chain written down before they pay. MEDVi is one of the few programmes at this price point that names its partner pharmacies, names the prescriber network, and publishes a full cancellation and refund policy. It also suits people weighing a compounded plan against a branded one on the same platform, since it prices both.
- Pricing
- Compounded GLP-1 injections are an introductory $99 for the first month and $199 for refills (checked 31 October 2026). Compounded GLP-1 tablets start at $249, with no period stated on the card (checked 1 November 2026). Branded routes are sold differently, as a $99 membership plus the cost of the medication itself (checked 1 November 2026). MEDVi states there is no membership fee or hidden fee on the compounded plans, that no insurance is required, that shipping is free, and that the plans are HSA/FSA approved.
- Access
- Compounded GLP-1 injections and tablets, plus branded GLP-1 routes sold as a membership plus medication cost. Prescriptions are issued only after an online consultation with an independent licensed provider. MEDVi states that compounded medications are dispensed by state-licensed pharmacies but are not FDA approved, and that although the facilities are FDA-regulated the medicines are not FDA-approved or evaluated for safety, efficacy or quality.
Is MEDVi cheaper than Ro?
On the published figures, yes, and the gap is the medicine. MEDVi's compounded GLP-1 injections are an introductory $99 for the first month and $199 at refill, with no membership (checked 31 October 2026). Ro's lowest total at the starting dose is $188 for month one and $298 a month after on the monthly plan, or $223 with the membership prepaid for a year (checked 31 October 2026). Ro's medication price rises with the dose, and MEDVi does not say whether its price changes with the dose.
The two prices buy different products: compounded medication at MEDVi, which is not FDA-approved, and a brand-name, FDA-approved medicine at Ro. With insurance coverage, Ro says your medication cost may be your copay, which MEDVi's compounded plans cannot match because they do not use insurance. For both over 3, 6 and 12 months, read daily, see the US GLP-1 price index.
Brand-name or compounded: what each sells
Ro's weight-loss pages, read on 18 October 2026, list brand-name medicines only: the Wegovy pill and pen, the Foundayo pill, Zepbound and Ozempic. The word "compound" does not appear. A Ro-affiliated provider decides which, if any, you are prescribed, and Ro says it only charges the membership if you are eligible.
MEDVi's main plans are compounded GLP-1 injections and tablets, dispensed by one of three named pharmacies. MEDVi states that these are not FDA approved and that, although the facilities are FDA-regulated, the medicines are not evaluated by the FDA for safety, efficacy or quality. MEDVi also sells branded medicines through a separate membership route, priced on the MEDVi review.
Who each suits
Ro suits a buyer who wants a brand-name, FDA-approved medicine, who may have insurance coverage to check, and who wants the price at every dose published before paying. It costs more at the starting dose, the membership and the medication are separate subscriptions that each need cancelling, and the membership fee is non-refundable once paid.
MEDVi suits a buyer who wants the lower first-month and refill figures, accepts a compounded medicine that is not FDA-approved, and wants the supply chain written down: MEDVi names its pharmacies, its prescriber network and its refund terms. The first-month price is an offer, the refill price is the ongoing cost, and the public record below is part of the decision.
The public record: FDA letter, lawsuits and the OpenLoop breach
We found no FDA warning letter addressed to Ro on a search of fda.gov on 18 October 2026, which is "none found" rather than proof. On 20 February 2026 the FDA issued warning letter 721455 to MEDVi, LLC over the labelling and marketing of its compounded semaglutide and tirzepatide products, which MEDVi still sells; the FDA's page showed no close-out on 18 October 2026.
Court records read on 28 October 2026 show MEDVi, LLC as a defendant in three federal cases in the Central District of California: a Telephone Consumer Protection Act case over marketing texts that settled and was dismissed in May 2026, a class action under California's anti-spam law filed in March 2026, and a third class action docketed in April 2026 whose complaint we could not read. None is a finding against MEDVi. The data breach that appears next to MEDVi's name in search results is at OpenLoop Health, the prescriber network MEDVi names on its own pages, which learned on 7 January 2026 that an unauthorised party had taken names, addresses, email addresses, dates of birth and medical information; neither company has said whether MEDVi customers were included. Our Ro review records no lawsuit or breach.
The public ratings point in different directions. The BBB rates Ro A+ with 747 complaints in three years (read 18 October 2026) and MEDVi F with 782 (read 22 October 2026); Trustpilot shows 3.9 from 7,231 reviews for Ro (read 18 October 2026) and 4.3 from 15,102 for MEDVi (read 26 October 2026). A complaint count and a review score measure different things. The Ro review and the MEDVi review set out the complaint themes behind each figure.
How to choose
Ro sells FDA-approved brand-name medication behind a membership, with an insurance check and the price at every dose published; MEDVi sells compounded GLP-1 at a lower figure with no membership, and names its pharmacies and refund terms. Ro's public record is clean on the FDA; MEDVi's carries a warning letter, open lawsuits and a breach at its prescriber network. This page sets out what each states. It does not rank one above the other.
The right provider is the one that can explain eligibility, costs, side effects, refills, and support before you commit. Avoid treating GLP-1 access as a generic checkout flow; consultation is required and availability varies.
Pricing and access
Ro: membership $39 for the first month, then $74 to $149 a month by plan, plus medication from $149 a month at the starting dose and Zepbound from $299, so $298 a month at the lowest price on the monthly plan (checked 31 October 2026). MEDVi: an introductory $99 for the first month of compounded GLP-1 injections, then $199 for refills, with no membership fee on the compounded plans (checked 31 October 2026).
Brand-name medication only at Ro: the Wegovy pill and pen, the Foundayo pill, Zepbound and Ozempic. Compounded GLP-1 injections and tablets at MEDVi, which states they are not FDA approved, with branded routes sold separately. A licensed provider decides which, if any, is right for you.
Users comparing local care can also review PCF city hubs such as Miami, New York, and Los Angeles.
Each provider has its own review: the Ro weight loss review sets out its membership plans, its medication price at every dose, its insurance check and its cancellation terms in full, and the MEDVi review sets out its introductory and refill prices, its three pharmacies, its refund policy, its FDA warning letter and the lawsuits and data breach attached to its name.
Consultation, delivery, and follow-up
Both begin with an online intake. Ro says its licensed providers decide whether you are eligible and that it only charges the membership if you are; the first month is refunded if you are not eligible for GLP-1s. MEDVi takes payment, then an OpenLoop Health clinician consults with you and decides; MEDVi refunds in full if you are disqualified for a medical reason.
Ro says cash-pay medication ships to your door in under a week and insured medication is picked up at your pharmacy after a coverage check of one to two weeks. MEDVi says shipping is free and discreet, from one of its three named pharmacies.
If a provider cannot clearly explain who reviews your intake, how side effects are handled, or what happens when your refill is due, keep comparing before you proceed.
Ro.co
Ro is the clearest of the big brands on price: it prints every membership plan and the medication price at each dose. It is not the cheapest way to a GLP-1, because the membership sits on top of brand-name medication. It makes most sense if you want a brand-name medicine, a long-established company, or a free check on whether insurance will pay.
Pros
- Publishes every membership plan and the medication price at each dose
- Brand-name, FDA-approved medicines only
- Free insurance check, with an insurance concierge that handles the paperwork
- The first month is refunded if you are not eligible for GLP-1s
- Long-established: BBB lists the business as started in April 2017, with an A+ rating
Considerations
- Two charges: the membership is on top of the medication, so the starting-dose total is $298 a month on the monthly plan
- Medication prices rise with the dose: up to $299 for the Wegovy pill, $399 for the Wegovy pen and $449 for Zepbound (with manufacturer offers), read 18 October 2026
- Once paid, the membership fee is non-refundable, and prescription products are final sale
- Cancellation must be made at least 48 hours before the renewal date or the next membership fee is charged
- No compounded option, so it is not the cheapest route to a GLP-1
MEDVi
MEDVi is the strongest option on this list for a buyer who wants to know who compounds the medicine, who prescribes it and what happens if they stop. The disclosure is genuinely better than its competitors'; the refund terms, once read, are tighter than the marketing implies.
Pros
- Unusually complete disclosure: pharmacies, prescriber network, medical entity and refund terms are all published
- Both compounded and branded routes priced on the same platform, so the two can be compared directly
- Full refund if a clinician disqualifies you on medical grounds
- 24/7 support and a patient portal for messaging and progress tracking
Considerations
- No refund for the month in which you cancel, or for any prior month, on a monthly plan
- Cancellation must reach support at least 72 hours before the next billing date or the next cycle is charged
- Care coaching and dietician visits are qualified as "subject to insurance and copays eligibility", so "included" is conditional
- Several advertised categories, peptides and longevity, women’s health, hair, skin and supplements, are marked "coming soon" rather than available (checked 18 September 2026)
- Marketing carries large self-reported outcome figures that MEDVi's own footnote describes as not typical
Related research paths
Related comparison paths
Move from this comparison into the peptide pages and relevant clinic profiles.
Frequently asked questions
Is MEDVi cheaper than Ro?
On the published figures, yes: MEDVi's compounded GLP-1 injections are an introductory $99 for the first month and $199 at refill with no membership, against Ro's $298 a month at the starting dose on a monthly plan (a $149 membership plus medication from $149), or $223 with the membership prepaid for a year. MEDVi's price buys compounded medication, which is not FDA-approved; Ro's buys a brand-name product. Checked 31 October 2026.
Does Ro sell compounded GLP-1 like MEDVi?
No. Ro's weight-loss pages, read on 18 October 2026, list FDA-approved brand-name medicines only: the Wegovy pill and pen, the Foundayo pill, Zepbound and Ozempic. MEDVi's main plans are compounded GLP-1 injections and tablets, which MEDVi states are not FDA approved.
Is Ro or MEDVi FDA-approved?
Neither company is FDA-approved; the FDA approves medicines, not telehealth providers. Ro sells FDA-approved brand-name medicines. MEDVi's main plans are compounded GLP-1 injections and tablets, which are not FDA approved. We found no FDA warning letter addressed to Ro (18 October 2026); MEDVi received one on 20 February 2026 over the labelling and marketing of its compounded products.
Does Ro take insurance, and does MEDVi?
Ro offers a free insurance check for Ozempic, Wegovy and the Zepbound pens and says that with coverage your medication cost may be your copay; the membership fee still applies. MEDVi says no insurance is required on its compounded plans and that they are HSA/FSA approved.
Which is easier to cancel, Ro or MEDVi?
Both publish their terms. Ro: cancel in your account or by email at least 48 hours before renewal; the membership fee is non-refundable once paid and prescription products are final sale, though the first month is refunded if you are not eligible. MEDVi: cancel at least 72 hours before the next billing date, with a full refund inside the first 72 hours before any service or on medical disqualification, and none for the month of cancellation. Ro's membership and any prepaid medication plan are separate subscriptions that each need cancelling.
Has MEDVi been sued or had a data breach?
Court records read on 28 October 2026 show MEDVi, LLC as a defendant in three federal cases: one over marketing texts that settled in 2026, and two class actions, one under California's anti-spam law, that were open on the last date we could read. None is a finding against MEDVi. The breach attached to its name is at OpenLoop Health, its prescriber network, in January 2026; neither company has said whether MEDVi customers' data was included. Our Ro review records no lawsuit or breach.
Do Ro and MEDVi serve every state?
Neither publishes a list. Ro says availability varies by state, insurance and clinical eligibility. MEDVi says availability depends on the state you are in and on a clinician's decision. You find out at intake.
Editorial transparency
PCF separates clinical information from sponsored links. Some provider links may be sponsored, but all providers are described with cautious medical language: treatment may be available, consultation is required, and clinical appropriateness is determined by a licensed professional.
Provider details can change. Before starting any program, verify the current price, medication path, clinician credentials, pharmacy process, shipping terms, and follow-up support directly with the provider.